Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia
Raúl Istúriz(Pfizer (United States)), Luis Jódar(Pfizer (United States)), Paula Peyrani(University of Louisville), Wesley H. Self(Vanderbilt University Medical Center), Richard G. Wunderink(Northwestern University), Senen Pena Oliva(Saint Louis University), Ronika Alexander(Pfizer (United States)), Julio A. Ramírez(Norton Healthcare), Francis L. Counselman(Eastern Virginia Medical School), Luis Ostrosky‐Zeichner(The University of Texas Health Science Center), Michael W. Pride(Pfizer (United States)), Sharon Gray(Pfizer (United States)), Carlos G. Grijalva(Vanderbilt University Medical Center), Qin Jiang(Pfizer (United States)), John M. McLaughlin(Pfizer (United States)), Gregory Volturo(University of Massachusetts Chan Medical School), J. Scott Overcash(Precision Research Institute), Robert Sherwin(Wayne State University), Timothy L. Wiemken(University of Louisville), Thomas M. File(Summa Health System), Kimbal D. Ford(Pfizer (United States))
Cited by 80
Related Papers
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2015|4k
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
|European Respiratory Journal|2017|1.4k